Leaflet TRAZEC 120mg film-coated tablets

Product code:
W51757007
Quantity:
360
Indicated for:
type 2 diabetes mellitus
Route of administration:
oral
Substance:
nateglinide (antidiabetic)
ATC
A10BX03 — Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins

Precautions:

Hypoglycemia

Hypoglycemia

This medicine may lower blood sugar.

Nateglinide is an antidiabetic medication used to control blood sugar levels in patients with type 2 diabetes. It belongs to the meglitinide class and works by stimulating insulin secretion from the pancreas, particularly after meals.

The medication is taken orally, usually before meals, with the dose adjusted based on blood glucose levels. Common side effects include hypoglycemia, nausea, and weight gain.

Nateglinide is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or hypersensitivity to the active substance. It should also be used with caution in patients with hepatic or renal impairment.

This medication is an effective option for controlling postprandial blood sugar levels, helping to prevent complications associated with type 2 diabetes.

General data about TRAZEC 120mg

Substance:
nateglinide
Date of latest medicines list:
01-07-2013
Product code:
W51757007
Concentration:
120mg
Pharmaceutical form:
film-coated tablets
Quantity:
360
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for nateglinide

  • 120mg
  • 180mg
  • 60mg